ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,3,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
7,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
7,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,1,Biliary ischaemia,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
8,2,Cholangitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
8,3,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
9,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
11,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
12,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
12,3,Portal vein pressure increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
